Yale Cancer Center develops new flu vaccination strategy



This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW HAVEN, Conn. (AP) — Researchers at the Yale Cancer Center have developed a new vaccination strategy that they say greatly reduces the risk of potentially life-threatening flu infections in cancer patients that are the most vulnerable.

Studies have shown that patients with cancers of the immune system are extremely susceptible to common infections and a one-time flu shot is not the remedy.

Yale's new strategy consists of offering patients a high-dose flu vaccine followed by a second high-dose booster shot one month later.

Dr. Andrew Branagan says the vaccination strategy lowered the infection rate among patients to 6 percent and it improved protection against all flu strains covered by the vaccine in 66 percent of patients.

Yale's findings were presented Sunday at the American Society of Hematology's annual meeting in Orlando, Florida.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast